George Fotiades is a chief executive and board director with a career focused on building and scaling global healthcare businesses. He previously served as CEO of Cantel Medical, leading its transformation and $4.6 billion sale to Steris plc in 2021. Earlier, he was CEO and Executive Chairman of Catalent, helping establish it as a leading global CDMO, and President and COO of Cardinal Health, where he founded its Pharmaceutical Technologies and Services segment. He has also worked as an operating partner at Five Arrows (Rothschild & Co.) and serves on the boards of AptarGroup, Prologis, Curia, and RiteDose.
Our Team
George Fotiades
Chair
Quote from George...
"I am excited to work alongside Lucy and the team to broaden our network, strengthen those partnerships, and to help take what has been built here to a wider market as the business grows."
About George
George Fotiades joined eXmoor Pharma as Chair in April 2026, bringing extensive board-level and executive leadership experience from across the global healthcare and CDMO sector.
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.